MIT researchers have developed a new in-home device that can help monitor Parkinson’s patients by tracking their gait, reports Hiawatha Bray for The Boston Globe. “We know very little about the brain and its diseases,” says Professor Dina Katabi. “My goal is to develop non-invasive tools that provide new insights about the functioning of the brain and its diseases.”
Popular Science reporter Philip Kiefer writes that MIT researchers have developed an in-home device that could be used to track the progression of symptoms in Parkinson’s patients. “We can’t really ask patients to come to the clinic every day or every week,” explains graduate student Yingcheng Liu. “This technology gives us the possibility to continuously monitor patients, and provide more objective assessments.”
Doctoral research specialist Morteza Sarmadi speaks with Emily Henderson from News Medical Life Sciences about his work with Prof. Robert Langer and research scientist Ana Jaklenec in developing microparticles that are able to deliver self-boosting vaccines. “We believe this technique can significantly reduce the need to visit a healthcare provider to receive booster shots, a major challenge in remote areas without sophisticated healthcare resources,” says Sarmadi.
Researcher Hojun Li and his team have developed a new Covid-19 at-home test that looks “specifically at the levels of neutralizing antibodies and either give a precise level or a ‘low,’ ‘medium,’ ‘high’ reading, providing more actionable information,” reports Karen Weintraub for USA Today.
Hojun Li, a clinical investigator at the Koch Institute, speaks with Juli McDonald on CBS Boston about his efforts to develop a test that can determine a person’s Covid immunity. “We wanted to develop a way in which we could very quickly and easily assess whether [immunocompromised people] were still protected from that vaccine or that previous infection they had,” said Li.
Daily Beast reporter Tony Ho Tran writes that a new paper test developed by MIT researchers could be used to help determine a person’s immune response to Covid-19. “The researchers believe that the new test can not only help folks find out if they should get boosted,” writes Tran, “but also help the most vulnerable populations make sure they’re protected against the coronavirus, and help people make more informed decisions on what kinds of activities they should feel safe doing.”
Boston.com reporter Madeleine Aitken writes that MIT researchers have created a new blood test that can measure immune protection against Covid-19. The new test measures the “level of neutralizing antibodies in a blood sample, using the same type of ‘lateral flow’ technology as antigen tests,” writes Aitken.
Researchers from MIT and Harvard have developed a “3D-printed ‘lab-on-a-chip’ that could detect Covid-19 immunity levels and Covid infections from saliva within two hours,” reports Ben Leonard and Ruth Reader for Politico.
Boston Herald reporter Rick Sobey writes that MIT researchers have developed a blood test that can predict Covid-19 immunity. “The MIT researchers created a paper test that measures the level of neutralizing antibodies in a blood sample, which could help people decide what protections they should take against infection,” writes Sobey. “Their test uses the same type of 'lateral flow' technology as most rapid antigen tests for Covid.”
CAMP4, a startup founded by Prof. Richard Young, is developing a new class of RNA-based therapies to treat genetic diseases, reports Ryan Cross for The Boston Globe. The “startup’s experimental approach will allow it to dial up the output of genes to treat genetic diseases, with an initial focus on a severe form of epilepsy and life-threatening live diseases,” writes Cross.
Scientists at MIT are developing a self-boosting vaccine that can provide multiple doses of a vaccine via a single injection, reports Darko Manevski for Newsweek. The technology “could be particularly useful for administering childhood vaccinations in regions where people do not have regular access to medical care,” writes Manevski.
MIT scientists are developing self-boosting vaccine technology that could allow people to receive all of their vaccine doses in one shot, reports The Economist. This technology “would be a game-changer, not only for future pandemics but also for vaccination programs in remote regions where it is harder to deliver boosters,” The Economist notes.
Wall Street Journal reporter Daniela Hernandez spotlights the work of Media Lab Research Scientist Andreas Mershin in developing sensors that can detect and analyze odors. Mershin “is focusing on medical applications of olfaction technology. Inspired by dogs that have demonstrated an ability to sniff out malignancies in humans, he’s working on an artificial-intelligence odor-detection system to detect prostate cancer.”
STAT reporters Katie Palmer and Casey Ross spotlight how Prof. Regina Barzilay has developed an AI tool called Mirai that can identify early signs of breast cancer from mammograms. “Mirai’s predictions were rolled into a screening tool called Tempo, which resulted in earlier detection compared to a standard annual screening,” writes Palmer and Ross.
MIT researchers are developing innovations aimed at improving Covid-19 diagnostics, including an atomic-level test designed to increase testing accuracy, reports Steven Zeitchik for The Washington Post. Professor James Collins and his team are developing “a mask that uses freeze-dried technology to detect the coronavirus.”